WS #11976
Holding: newest synthesis is 129d 13h old
Kenvue gains after court victory in Tylenol-autism class action, but prior revival of 500+ lawsuits remains a risk.
Kenvue Tylenol-autism litigation
Kenvue gains after court victory in Tylenol-autism class action, but prior revival of 500+ lawsuits remains a risk.